Location History:
- Brussels, BE (2010)
- Namue, BG (2013)
- Temploux, BE (2019)
Company Filing History:
2 out of 3,923 
2 out of 33 
1 out of 1 
Years Active: 2010-2019
Title: **Sebastien Hannedouche: Innovator in Organic Compound Modulation**
Introduction
Sebastien Hannedouche, an accomplished inventor based in Temploux, Belgium, has significantly contributed to the field of organic chemistry. With three patents to his name, Hannedouche is recognized for his innovative approaches to understanding and modulating receptor interactions, which hold potential implications in medical treatments.
Latest Patents
Hannedouche's latest patents showcase his focus on modulators of specific receptor interactions. The first patent involves modulators of the interaction between G-protein coupled receptor 15 (GPR15) and c10orf99. This invention includes small chemical molecules, antibodies, or other therapeutic proteins aimed at providing medical treatments. The second patent pertains to identifying modulators that inhibit the binding between Epstein-Barr virus-induced receptor 2 (EBi2) and cholesterol-derived ligands. Similar to his first patent, this involves the use of small chemical molecules, antibodies, or therapeutic proteins, along with methods for medical treatment and identifying effective modulators.
Career Highlights
Sebastien Hannedouche has worked with prestigious companies including Novartis AG and Euroscreen S.A. These experiences have allowed him to hone his expertise and develop innovations that push the boundaries of current medical treatments. His work reflects a commitment to advancing the field through novel approaches.
Collaborations
Throughout his career, Hannedouche has collaborated with talented individuals such as Birgit Uta Baumgarten and Rocco Falchetto. These partnerships have been instrumental in fostering an environment of innovation, enabling the exploration of new ideas and development of groundbreaking patented technologies.
Conclusion
Sebastien Hannedouche stands out as a pivotal figure in the realm of organic compounds and modulations. Through his patents and collaborative efforts, he continues to pave the way for advancements in medical treatments, emphasizing the impact that dedicated inventors can have on the future of healthcare.